LncRNA KCNQ1OT1 sponges miR-15a to promote immune evasion and malignant progression of prostate cancer via up-regulating PD-L1

被引：0
|
作者：
Qi-Hua Chen
Bo Li
De-Guo Liu
Biao Zhang
Xian Yang
Ya-Ling Tu
机构：
[1] Hunan University of Chinese Medicine,Department of Andrology, The First Hospital
[2] Hunan University of Chinese Medicine,Graduate School
[3] Hunan University of Chinese Medicine,Department of Dermatology, The First Hospital
来源：
Cancer Cell International | / 20卷
关键词：
Prostate cancer; KCNQ1OT1; MiR-15a; PD-L1; Immune evasion;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] LncRNA KCNQ1OT1 regulates proliferation and cisplatin resistance in tongue cancer via miR-211-5p mediated Ezrin/Fak/Src signaling
    Zhang, Shanyi
    Ma, Hanyu
    Zhang, Daming
    Xie, Shule
    Wang, Weiwei
    Li, Qunxing
    Lin, Zhaoyu
    Wang, Youyuan
    CELL DEATH & DISEASE, 2018, 9
  • [42] RETRACTION: KCNQ1OT1 accelerates gastric cancer progression via miR-4319/DRAM2 axis (Retraction of Vol 34, Pg 1, 2020)
    Wang, J.
    Wu, F.
    Li, Y.
    Pang, L.
    Wang, X.
    Kong, G.
    Zhang, T.
    Yu, D.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2021, 35
  • [43] The immune checkpoint regulator PD-L1 expression are associated with clinical progression in prostate cancer
    He, Juan
    Yi, Min
    Tan, Lingfeng
    Huang, Jianghua
    Huang, Lin
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [44] The immune checkpoint regulator PD-L1 expression are associated with clinical progression in prostate cancer
    Juan He
    Min Yi
    Lingfeng Tan
    Jianghua Huang
    Lin Huang
    World Journal of Surgical Oncology, 19
  • [45] LncRNA TTN-AS1 sponges miR-376a-3p to promote colorectal cancer progression via upregulating KLF15
    Wang, Yanhua
    Jiang, Fang
    Xiong, Yan
    Cheng, Xiaoliang
    Qiu, Zhimin
    Song, Rongfeng
    LIFE SCIENCES, 2020, 244
  • [46] Isobutyric Acid Promotes Immune Evasion in Colorectal Cancer via Increased PD-L1 Expression
    Lin, Qiuhua
    Wang, Han
    Chen, Wenbo
    Wei, Xinjie
    Chen, Jinglian
    Deng, Ying
    Wei, Chunyin
    Lai, Hao
    Mo, Xianwei
    Tang, Weizhong
    Luo, Tao
    CANCER MEDICINE, 2024, 13 (21):
  • [47] Nonsense-mutation in TP53 improves clinical benefits of PD-1/PD-L1 blockade immunotherapy in advanced urothelial carcinoma through up-regulating PD-L1 expression via miR-34a
    Chen, S.
    Wang, X.
    Zheng, J. H.
    EUROPEAN UROLOGY, 2021, 79 : S623 - S623
  • [48] lncRNA OGFRP1 functions as a ceRNA to promote the progression of prostate cancer by regulating SARM1 level via miR-124-3p
    Yan, Keqiang
    Hou, Lifang
    Liu, Tiantian
    Jiao, Wei
    Ma, Qian
    Fang, Zhiqing
    Zhang, Shimin
    Song, Daoqing
    Liu, Jikai
    Gao, Xinghua
    Fan, Yidong
    AGING-US, 2020, 12 (10): : 8880 - 8892
  • [49] Long Noncoding RNA KCNQ1OT1 Promotes the Progression of Non-Small Cell Lung Cancer via Regulating miR-204-5p/ATG3 Axis
    Kang, Yan
    Jia, Yaoli
    Wang, Qilong
    Zhao, Qianru
    Song, Meng
    Ni, Ran
    Wang, Jing
    ONCOTARGETS AND THERAPY, 2019, 12 : 10787 - 10797
  • [50] SChLAP1 contributes to non-small cell lung cancer cell progression and immune evasion through regulating the AUF1/PD-L1 axis
    Du, Zhonghai
    Niu, Shuxian
    Wang, Juan
    Wu, Jun
    Li, Sheng
    Yi, Xiuxiu
    AUTOIMMUNITY, 2021, 54 (04) : 225 - 233
12345